2024-10-30 21:23:11
Innovent Announces First Patient Dosed in the Phase 2 Clinical Trial of IBI302, a First-in-class Ophthalmic Anti-VEGF and Anti-Complement Bispecific Fusion Protein for Neovascular Age-Related Macular Degeneration
Corporate/ 2023-07-23
Innovent Announces First Patient Dosed i...

SAN FRANCISCO and SUZHOU,China,April 29,2021-- Innovent Biologics,Inc. ("Innovent") (HKEX: 01801),a world-class biopharmaceutical ...

Hilco Industrial Acquires All Machinery & Equipment from Legacy Pharmaceutical Switzerland
Health/ 2023-07-22
Hilco Industrial Acquires All Machinery ...

BASEL,Switzerland,April 29,2021-- Hilco Industrial Acquisitions,an Amsterdam-based Industrial Asset Disposition and Acquisition Company,acqu...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release